212 related articles for article (PubMed ID: 34014280)
1. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH.
Bravo M; Raurell I; Barberá A; Hide D; Gil M; Estrella F; Salcedo MT; Augustin S; Genescà J; Martell M
Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34014280
[TBL] [Abstract][Full Text] [Related]
2. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH.
Bravo M; Raurell I; Hide D; Fernández-Iglesias A; Gil M; Barberá A; Salcedo MT; Augustin S; Genescà J; Martell M
Sci Rep; 2019 Dec; 9(1):20183. PubMed ID: 31882668
[TBL] [Abstract][Full Text] [Related]
3. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.
Miyao M; Kotani H; Ishida T; Kawai C; Manabe S; Abiru H; Tamaki K
Lab Invest; 2015 Oct; 95(10):1130-44. PubMed ID: 26214582
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.
Wang W; Zhao C; Zhou J; Zhen Z; Wang Y; Shen C
PLoS One; 2013; 8(10):e76538. PubMed ID: 24098525
[TBL] [Abstract][Full Text] [Related]
5. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase.
Fang ZQ; Ruan B; Liu JJ; Duan JL; Yue ZS; Song P; Xu H; Ding J; Xu C; Dou GR; Wang L
Hepatology; 2022 Sep; 76(3):742-758. PubMed ID: 35006626
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J
Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891
[TBL] [Abstract][Full Text] [Related]
8. Endothelial group IVA phospholipase A
Kawashita E; Ozaki T; Ishihara K; Kashiwada C; Akiba S
Life Sci; 2022 Apr; 294():120355. PubMed ID: 35093339
[TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
10. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein induces dysfunction of liver sinusoidal endothelial cell by down-regulation of silent information regulator 1.
Sun LJ; Yu JW; Shi YG; Zhang XY; Shu MN; Chen MY
J Med Virol; 2018 May; 90(5):926-935. PubMed ID: 29350417
[TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time measurement of endothelin-1-induced contraction in single non-activated hepatic stellate cells.
Dohi N; Yamaguchi M; Hase R; Suzuki R; Wakabayashi Y; Nishiyama R; Saito SY; Ishikawa T
PLoS One; 2021; 16(8):e0255656. PubMed ID: 34343209
[TBL] [Abstract][Full Text] [Related]
13. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.
Guo Q; Furuta K; Islam S; Caporarello N; Kostallari E; Dielis K; Tschumperlin DJ; Hirsova P; Ibrahim SH
Front Immunol; 2022; 13():983255. PubMed ID: 36091042
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model.
Klaebel JH; Skjødt M; Skat-Rørdam J; Rakipovski G; Ipsen DH; Schou-Pedersen AMV; Lykkesfeldt J; Tveden-Nyborg P
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752351
[TBL] [Abstract][Full Text] [Related]
15. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
16. Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries.
Liang F; Yang S; Yao L; Belardinelli L; Shryock J
Hypertension; 2012 Mar; 59(3):705-11. PubMed ID: 22311911
[TBL] [Abstract][Full Text] [Related]
17. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
18. A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.
Rodríguez S; Raurell I; Torres-Arauz M; García-Lezana T; Genescà J; Martell M
Sci Rep; 2017 Jan; 7():40461. PubMed ID: 28084470
[TBL] [Abstract][Full Text] [Related]
19. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
Ahsan F; Oliveri F; Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Rutkofsky IH
Cureus; 2020 Sep; 12(9):e10446. PubMed ID: 33072455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
